Bringing web 3.0 to medical research by delivering blockchain-enabled software solutions for clinical trials

ICO Details

Starting date
July 12th, 2021
Ending date
September 28th, 2021
Token Sale Hard Cap
Token Sale Soft Cap
Token Symbol
Token Type
Token Distribution
Private pre-sale - 5,00% - 8.750.000 $TRL
Retail pre-sale - 1,64% - 2.875.000 $TRL
Retail pre-sale launchpads - 0,86% - 1.500.000 $TRL
Late bird pre-sale - with super long lockups - 7,50% - 13.125.000 $TRL
Airdrop - 3,00% - 5.250.000 $TRL
Treasury - 24,00% - 42.000.000 $TRL
Triall Community Fund - 10,00% - 17.500.000 $TRL
Existing Investors - 12,50% - 21.875.000 $TRL
Advisors - 8,00% - 14.000.000 $TRL
Founding team - 10,00% - 17.500.000 $TRL
Growth, Acquisition & Marketing 9,50% 16.625.000 $TRL
Long-term Operations & Development 8,00% 14.000.000 $TRL
Initial Token Price
1 token $TRL = 0.20 USD
Participation Restrictions
$TRL utility tokens are not offered to citizens or residents of the United States of America, Puerto Rico, the U.S. Virgin Islands or any other possession of the United States, the People’s Republic of China, Cuba, Iran, North Korea, Syria, and any other country, state, or territory where it is prohibited to purchase, hold, or own cryptocurrency, virtual money, security tokens or utility tokens as well as a country, state, or territory where offering of utlity tokens is considered offering of securities under applicable law.

Triall is laying the groundwork for tomorrow’s digital playing field in clinical trials. We bring Web 3.0 to medical research by developing a digital ecosystem of blockchain-integrated software solutions. Our blockchain infrastructure makes medical data tamper-resistant and enables secure and efficient connections between the many isolated systems and parties involved in clinical research.

The clinical trial process typically takes 10 years and has become increasingly complex, data-heavy, and fragemented over the past decade. As a result, the majority of clinical trial stakeholders experience a lack of oversight over their clinical trial operations. This leads to significant delays, reiterations, and an enormous amount of unnecessary costs. Moreover, the industry is hampered by a growing number of data integrity issues as well as numerous cases of error and misconduct over the past years. All of these issues delay the patient’s access to new medicine and drive up their future price.

As the world’s first organization to implement blockchain in a live and running clinical trial, we are a frontrunner in applying blockchain to address two industry-wide needs: (1) promoting traceability and auditability of clinical trial operations, which have become increasingly complex and data-heavy; and (2) enabling the safe and compliant transfer of clinical trial data between organizations and systems, thereby promoting interoperability and tackling data fragmentation.

Triall has been in development since 2017. We have a first working product that is used in real clinical trials today, and are backed by a growing community of partners and investors.

Project info
- Website:
- Founded: early 2018
- Industry: clinical trials (±$200B industry that evaluates the safety and efficacy of new therapeutics and vaccines in patients)
- Token ticker: $TRL
- Token type: ERC20
- Initial listing: Uniswap
- Listing price: $0,25
- Listing date: September
- IDOs: and
- Smart contract auditor: (100/100 audit report)

Core Team

Hadil Es-Sbai
President | CEO

Niel Klomp

Raymond van der Waal

Linda van de Burgwal

Mark van der Waal
Head of Design